ASTH (Astrana Health) Cash Flow for Dividends: $-3 Mil (TTM As of Mar. 2026)


ASTH Astrana Health Inc ASTH
87 GF Score
Price $43.48
GF Value $82.34
Valuation Significantly Undervalued
! 8 Warning Signs
View Full Analysis

What is Astrana Health Cash Flow for Dividends?

Astrana Health ASTH +2.98% 87 Cash Flow for Dividends is $-3 Mil as of Mar. 2026. GuruFocus rates ASTH with a GF Score™ of 87/100 and a GF Value™ of $82.34 (Significantly Undervalued). The stock has 8 warning signs investors should review.

Astrana Health's cash flow for dividends for the three months ended in Mar. 2026 was $-0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2026 was $-3 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Astrana Health's quarterly payment of dividends increased from Sep. 2025 ($-0 Mil) to Dec. 2025 ($-2 Mil) but then declined from Dec. 2025 ($-2 Mil) to Mar. 2026 ($-0 Mil).

Astrana Health's annual payment of dividends declined from Dec. 2023 ($-62 Mil) to Dec. 2024 ($-4 Mil) but then increased from Dec. 2024 ($-4 Mil) to Dec. 2025 ($-8 Mil).

Astrana Health Cash Flow for Dividends Related Terms

Astrana Health Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Astrana Health's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Astrana Health Cash Flow for Dividends Chart

Astrana Health Annual Data
Trend Mar16 Mar17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only -31.09 -14.03 -62.07 -4.04 -7.89

Astrana Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.46 -0.78 -0.10 -1.56 -0.10
ASTH
87GF Score
Astrana Health Inc ASTH
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Astrana Health Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of $-3 Mil mean?
Astrana Health (ASTH) has a Cash Flow for Dividends of $-3 Mil as of Mar. 2026. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Astrana Health and its competitors.
Is Astrana Health's Cash Flow for Dividends too high?
Astrana Health's current Cash Flow for Dividends is $-3 Mil. Overall, Astrana Health has a GF Score™ of 87/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Astrana Health's Cash Flow for Dividends compare to MD and SGRY?
Astrana Health's Cash Flow for Dividends of $-3 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Healthcare Providers & Services company?
A good Cash Flow for Dividends depends on the Healthcare Providers & Services industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Astrana Health and its competitors. Astrana Health's current Cash Flow for Dividends is $-3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Astrana Health stock overvalued right now?
Based on GuruFocus' analysis, Astrana Health (ASTH) is currently considered Significantly Undervalued. The stock's GF Value™ is $82.34, compared to a current price of $43.48 — trading 47.2% below its estimated fair value. The current Cash Flow for Dividends is $-3 Mil. Astrana Health's overall GF Score™ is 87/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Astrana Health (ASTH), the current Cash Flow for Dividends is $-3 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Astrana Health (ASTH) Overvalued in 2026?

Based on GuruFocus' analysis, Astrana Health stock appears to be undervalued. The current stock price of $43.48 is trading 47.2% below its estimated GF Value™ of $82.34. GuruFocus considers Astrana Health to be Significantly Undervalued.

Key valuation signals for ASTH:

  • Cash Flow for Dividends: $-3 Mil
  • GF Value™: $82.34 vs. price of $43.48 (47.2% below fair value)
  • GF Score™: 87/100 with 8 warning signs

No single metric tells the full story. See the ASTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Astrana Health Business Description

Other Exchanges 3AM:Germany
Address 1668 South Garfield Avenue, 2nd Floor, Alhambra, CA, USA, 91801
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
87GF Score

Get the complete analysis for ASTH

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$43.48
Price
$82.34
GF Value